查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386510

數位糖尿病管理市場報告：2030 年趨勢、預測與競爭分析

Digital Diabetes Management Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

數位糖尿病管理趨勢與預測

預計到 2030 年，全球數位糖尿病管理市場將達到 310 億美元，2024 年至 2030 年年複合成長率為 10.8%。該市場的主要促進因素是糖尿病盛行率的增加、技術進步以及擴大採用雲端基礎的企業糖尿病管理解決方案。全球數位糖尿病管理市場未來性，在醫院、家庭環境和診斷中心市場都有商機。

數位糖尿病管理市場洞察

Lucintel 預測，由於擴大採用用於糖尿病管理的智慧胰島素幫浦和用於自我給藥胰島素的胰島素貼片，穿戴式裝置在預測期內將繼續成為較大的細分市場。

在這個市場中，由於擴大採用遠端患者監護數位技術以及醫院內先進的數位糖尿病管理工具的現成可用，預計醫院仍將是最大的細分市場。

由於對連網糖尿病管理設備的需求增加、糖尿病管理和肥胖應用程式的快速採用以及該地區自我糖尿病管理意識的不斷增強，預計北美地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球數位糖尿病管理市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球數位糖尿病管理市場趨勢（2018-2023）與預測（2024-2030）
  • 全球數位糖尿病管理市場（按產品）
    • 智慧型血糖儀
    • 連續血糖測量系統
    • 智慧胰島素筆針
    • 智慧胰島素泵
    • 應用程式
  • 按類型分類的全球數位糖尿病管理市場
    • 穿戴式裝置
    • 手持裝置
  • 全球數位糖尿病管理市場（按最終用途）
    • 醫院
    • 主頁設定
    • 診斷中心

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球數位糖尿病管理市場（按地區）
  • 北美數位糖尿病管理市場
  • 歐洲數位糖尿病管理市場
  • 亞太數位糖尿病管理市場
  • 其他區域數位糖尿病管理市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球數位糖尿病管理市場成長機會（按產品）
    • 全球數位糖尿病管理市場成長機會（按類型）
    • 全球數位糖尿病管理市場的最終用途成長機會
    • 按地區分類的全球數位糖尿病管理市場成長機會
  • 全球數位糖尿病管理市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球數位糖尿病管理市場的能力擴張
    • 全球數位糖尿病管理市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Abbott Laboratories
  • Medtronic
  • F. Hoffmann-La Roche
  • Bayer
  • Lifescan
  • Dexcom
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings
  • B Braun Melsungen
簡介目錄

Digital Diabetes Management Trends and Forecast

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030 with a CAGR of 10.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

A more than 150-page report is developed to help in your business decisions.

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management by product, type, end use, and region

Digital Diabetes Management Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Smart Glucose Meter
  • Continuous Blood Glucose Monitoring System
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Apps

Digital Diabetes Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Wearable Devices
  • Handheld Devices

Digital Diabetes Management Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Home settings
  • Diagnostic Centers

Digital Diabetes Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

  • Abbott Laboratories
  • Medtronic
  • F. Hoffmann-La Roche
  • Bayer
  • Lifescan
  • Dexcom
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings
  • B Braun Melsungen

Digital Diabetes Management Market Insights

Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Within this market, hospitals will remain the largest segment due to increasing adoption of digital technologies for remote patient monitoring and easy availability of advanced digital diabetes management tools in hospitals.

North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the digital diabetes management market size?

Answer: The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030.

Q.2 What is the growth forecast for digital diabetes management market?

Answer: The global digital diabetes management market is expected to grow with a CAGR of 10.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the digital diabetes management market?

Answer: The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

Q4. What are the major segments for digital diabetes management market?

Answer: The future of the digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets.

Q5. Who are the key digital diabetes management market companies?

Answer: Some of the key digital diabetes management companies are as follows:

  • Abbott Laboratories
  • Medtronic
  • F. Hoffmann-La Roche
  • Bayer
  • Lifescan
  • Dexcom
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings
  • B Braun Melsungen

Q6. Which digital diabetes management market segment will be the largest in future?

Answer: Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Q7. In digital diabetes management market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps ), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Diabetes Management Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Digital Diabetes Management Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Digital Diabetes Management Market by Product
    • 3.3.1: Smart Glucose Meter
    • 3.3.2: Continuous Blood Glucose Monitoring System
    • 3.3.3: Smart Insulin Pens
    • 3.3.4: Smart Insulin Pumps
    • 3.3.5: Apps
  • 3.4: Global Digital Diabetes Management Market by Type
    • 3.4.1: Wearable Devices
    • 3.4.2: Handheld Devices
  • 3.5: Global Digital Diabetes Management Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Home settings
    • 3.5.3: Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Digital Diabetes Management Market by Region
  • 4.2: North American Digital Diabetes Management Market
    • 4.2.2: North American Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
  • 4.3: European Digital Diabetes Management Market
    • 4.3.1: European Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
    • 4.3.2: European Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
  • 4.4: APAC Digital Diabetes Management Market
    • 4.4.1: APAC Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
    • 4.4.2: APAC Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
  • 4.5: ROW Digital Diabetes Management Market
    • 4.5.1: ROW Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
    • 4.5.2: ROW Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Digital Diabetes Management Market by Product
    • 6.1.2: Growth Opportunities for the Global Digital Diabetes Management Market by Type
    • 6.1.3: Growth Opportunities for the Global Digital Diabetes Management Market by End Use
    • 6.1.4: Growth Opportunities for the Global Digital Diabetes Management Market by Region
  • 6.2: Emerging Trends in the Global Digital Diabetes Management Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Digital Diabetes Management Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Diabetes Management Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Medtronic
  • 7.3: F. Hoffmann-La Roche
  • 7.4: Bayer
  • 7.5: Lifescan
  • 7.6: Dexcom
  • 7.7: Sanofi
  • 7.8: Insulet Corporation
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: B Braun Melsungen